Trial Outcomes & Findings for Effect of Anesthesia on Post-operative Delirium in Elderly Patients Undergoing Hip Fracture Surgery (NCT NCT02213380)

NCT ID: NCT02213380

Last Updated: 2024-05-09

Results Overview

Post-operative delirium diagnosed with Confusion Assessment Method

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

950 participants

Primary outcome timeframe

in 7 days post operation

Results posted on

2024-05-09

Participant Flow

Participant milestones

Participant milestones
Measure
Group RA
Regional anesthesia(epidural, spinal, combined spinal and epidural anesthesia or nerve block) will be used in group RA
Group GA
General anesthesia (general anesthesia combined with peripheral nerve blockade, general anesthesia combined with spinal/epidural anesthesia or single general anesthesia) will be used in group GA.
Underwent Randomization
STARTED
476
474
Underwent Randomization
COMPLETED
471
471
Underwent Randomization
NOT COMPLETED
5
3
Per-protocol Analysis
STARTED
471
471
Per-protocol Analysis
COMPLETED
439
435
Per-protocol Analysis
NOT COMPLETED
32
36

Reasons for withdrawal

Reasons for withdrawal
Measure
Group RA
Regional anesthesia(epidural, spinal, combined spinal and epidural anesthesia or nerve block) will be used in group RA
Group GA
General anesthesia (general anesthesia combined with peripheral nerve blockade, general anesthesia combined with spinal/epidural anesthesia or single general anesthesia) will be used in group GA.
Underwent Randomization
Withdrawal by Subject
2
0
Underwent Randomization
Not treated
3
3
Per-protocol Analysis
Protocol Violation
32
36

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Group GA
n=471 Participants
General anesthesia(general anesthesia combined with peripheral nerve blockade, general anesthesia combined with spinal/epidural anesthesia or single general anesthesia) will be used in group GA.
Group RA
n=471 Participants
Regional anesthesia(epidural, spinal, combined spinal and epidural anesthesia or nerve block) will be used in group RA
Total
n=942 Participants
Total of all reporting groups
Age, Continuous
76.69 years
STANDARD_DEVIATION 6.57 • n=471 Participants
77 years
STANDARD_DEVIATION 6.5 • n=471 Participants
76.84 years
STANDARD_DEVIATION 6.53 • n=942 Participants
Sex: Female, Male
Female
352 Participants
n=471 Participants
343 Participants
n=471 Participants
695 Participants
n=942 Participants
Sex: Female, Male
Male
119 Participants
n=471 Participants
128 Participants
n=471 Participants
247 Participants
n=942 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Body Mass Index (BMI)
21.79 kg/m^2
STANDARD_DEVIATION 3.33 • n=471 Participants
21.71 kg/m^2
STANDARD_DEVIATION 3.48 • n=471 Participants
21.75 kg/m^2
STANDARD_DEVIATION 3.40 • n=942 Participants
Level of education
Illiterate
282 Participants
n=471 Participants
286 Participants
n=471 Participants
568 Participants
n=942 Participants
Level of education
Elementary school
119 Participants
n=471 Participants
124 Participants
n=471 Participants
243 Participants
n=942 Participants
Level of education
Secondary school or above
70 Participants
n=471 Participants
61 Participants
n=471 Participants
131 Participants
n=942 Participants
Type of fracture
Femoral neck fracture
264 Participants
n=471 Participants
278 Participants
n=471 Participants
542 Participants
n=942 Participants
Type of fracture
Fracture of femoral head
1 Participants
n=471 Participants
2 Participants
n=471 Participants
3 Participants
n=942 Participants
Type of fracture
Intertrochanteric
200 Participants
n=471 Participants
183 Participants
n=471 Participants
383 Participants
n=942 Participants
Type of fracture
Subtrochanteric
6 Participants
n=471 Participants
8 Participants
n=471 Participants
14 Participants
n=942 Participants
ASA class
I
17 Participants
n=471 Participants
22 Participants
n=471 Participants
39 Participants
n=942 Participants
ASA class
II
363 Participants
n=471 Participants
350 Participants
n=471 Participants
713 Participants
n=942 Participants
ASA class
III
90 Participants
n=471 Participants
98 Participants
n=471 Participants
188 Participants
n=942 Participants
ASA class
IV
1 Participants
n=471 Participants
1 Participants
n=471 Participants
2 Participants
n=942 Participants
Mini-mental State Examination
19.59 units on a scale
STANDARD_DEVIATION 6.41 • n=471 Participants
19.39 units on a scale
STANDARD_DEVIATION 6.27 • n=471 Participants
19.49 units on a scale
STANDARD_DEVIATION 6.34 • n=942 Participants
Pre-operative delirium
3 Participants
n=471 Participants
5 Participants
n=471 Participants
8 Participants
n=942 Participants
Comorbidities
Respiratory system disease
43 participants
n=471 Participants
37 participants
n=471 Participants
80 participants
n=942 Participants
Comorbidities
Central nervous system disease
57 participants
n=471 Participants
65 participants
n=471 Participants
122 participants
n=942 Participants
Comorbidities
Urinary system disease
117 participants
n=471 Participants
112 participants
n=471 Participants
229 participants
n=942 Participants
Comorbidities
Gastrointestinal system disease
145 participants
n=471 Participants
173 participants
n=471 Participants
318 participants
n=942 Participants
Comorbidities
Hematologic system disease
19 participants
n=471 Participants
18 participants
n=471 Participants
37 participants
n=942 Participants
Comorbidities
Cardiovascular system disease
300 participants
n=471 Participants
280 participants
n=471 Participants
580 participants
n=942 Participants

PRIMARY outcome

Timeframe: in 7 days post operation

Post-operative delirium diagnosed with Confusion Assessment Method

Outcome measures

Outcome measures
Measure
Group RA
n=471 Participants
Method of anesthesia: regional anesthesia method of anesthesia: Method of anesthesia includes: general anesthesia and regional anesthesia. General anesthesia(general anesthesia combined with peripheral nerve blockade, general anesthesia combined with spinal/epidural anesthesia or single general anesthesia) will be used in group GA. Regional anesthesia(epidural, spinal, combined spinal and epidural anesthesia or nerve block) will be used in group RA
Group GA
n=470 Participants
Method of anesthesia: general anesthesia method of anesthesia: Method of anesthesia includes: general anesthesia and regional anesthesia. General anesthesia(general anesthesia combined with peripheral nerve blockade, general anesthesia combined with spinal/epidural anesthesia or single general anesthesia) will be used in group GA. Regional anesthesia(epidural, spinal, combined spinal and epidural anesthesia or nerve block) will be used in group RA
Number of Participants With Post-operative Delirium in 7 Days Post Operation
29 Participants
24 Participants

SECONDARY outcome

Timeframe: within fist 7days post operation

Number of participants with delirium includes patients who had delirium in the post in the first 7 post-operative days. The severity of delirium was described using a severity score from 0 (no delirium) to 39 (highest severity) and subtypes of delirium as hyperactive, hypoactive or mixed.

Outcome measures

Outcome measures
Measure
Group RA
n=29 Participants
Method of anesthesia: regional anesthesia method of anesthesia: Method of anesthesia includes: general anesthesia and regional anesthesia. General anesthesia(general anesthesia combined with peripheral nerve blockade, general anesthesia combined with spinal/epidural anesthesia or single general anesthesia) will be used in group GA. Regional anesthesia(epidural, spinal, combined spinal and epidural anesthesia or nerve block) will be used in group RA
Group GA
n=24 Participants
Method of anesthesia: general anesthesia method of anesthesia: Method of anesthesia includes: general anesthesia and regional anesthesia. General anesthesia(general anesthesia combined with peripheral nerve blockade, general anesthesia combined with spinal/epidural anesthesia or single general anesthesia) will be used in group GA. Regional anesthesia(epidural, spinal, combined spinal and epidural anesthesia or nerve block) will be used in group RA
Number of Participants With Post-operative Delirium
1 episode of POD
16 Participants
10 Participants
Number of Participants With Post-operative Delirium
2 episodes of POD
5 Participants
10 Participants
Number of Participants With Post-operative Delirium
>=3 episodes of POD
8 Participants
4 Participants

SECONDARY outcome

Timeframe: within first 7days post operation

The worst severity scores of delirium was diagnosed with the DRS-R-98 within 7 days

Outcome measures

Outcome measures
Measure
Group RA
n=29 Participants
Method of anesthesia: regional anesthesia method of anesthesia: Method of anesthesia includes: general anesthesia and regional anesthesia. General anesthesia(general anesthesia combined with peripheral nerve blockade, general anesthesia combined with spinal/epidural anesthesia or single general anesthesia) will be used in group GA. Regional anesthesia(epidural, spinal, combined spinal and epidural anesthesia or nerve block) will be used in group RA
Group GA
n=24 Participants
Method of anesthesia: general anesthesia method of anesthesia: Method of anesthesia includes: general anesthesia and regional anesthesia. General anesthesia(general anesthesia combined with peripheral nerve blockade, general anesthesia combined with spinal/epidural anesthesia or single general anesthesia) will be used in group GA. Regional anesthesia(epidural, spinal, combined spinal and epidural anesthesia or nerve block) will be used in group RA
Severity of Delirium
23.48 score on a scale
Standard Deviation 7.16
24.22 score on a scale
Standard Deviation 7.04

SECONDARY outcome

Timeframe: within first 7 days post operation

The subtypes of delirium diagnosed with the Delirium Rating Scale-Revised-98 (DRS-R-98). Patients with the hyperactive subtype may be agitated, disoriented, and delusional, and may experience hallucinations. This presentation can be confused with that of schizophrenia, agitated dementia, or a psychotic disorder.

Outcome measures

Outcome measures
Measure
Group RA
n=29 Participants
Method of anesthesia: regional anesthesia method of anesthesia: Method of anesthesia includes: general anesthesia and regional anesthesia. General anesthesia(general anesthesia combined with peripheral nerve blockade, general anesthesia combined with spinal/epidural anesthesia or single general anesthesia) will be used in group GA. Regional anesthesia(epidural, spinal, combined spinal and epidural anesthesia or nerve block) will be used in group RA
Group GA
n=24 Participants
Method of anesthesia: general anesthesia method of anesthesia: Method of anesthesia includes: general anesthesia and regional anesthesia. General anesthesia(general anesthesia combined with peripheral nerve blockade, general anesthesia combined with spinal/epidural anesthesia or single general anesthesia) will be used in group GA. Regional anesthesia(epidural, spinal, combined spinal and epidural anesthesia or nerve block) will be used in group RA
The Subtypes of Delirium Diagnosed in 7 Days Post Operation
No motor
9 Participants
4 Participants
The Subtypes of Delirium Diagnosed in 7 Days Post Operation
Hyperactive
16 Participants
16 Participants
The Subtypes of Delirium Diagnosed in 7 Days Post Operation
Hypoactive
2 Participants
1 Participants
The Subtypes of Delirium Diagnosed in 7 Days Post Operation
Mixed motor
2 Participants
3 Participants

SECONDARY outcome

Timeframe: 30 days after surgery

Population: 6 patients in RA were lost to 30-day follow-up and 24 patients in GA were lost to 30-day follow-up.

Mortality within 30 days post operation

Outcome measures

Outcome measures
Measure
Group RA
n=465 Participants
Method of anesthesia: regional anesthesia method of anesthesia: Method of anesthesia includes: general anesthesia and regional anesthesia. General anesthesia(general anesthesia combined with peripheral nerve blockade, general anesthesia combined with spinal/epidural anesthesia or single general anesthesia) will be used in group GA. Regional anesthesia(epidural, spinal, combined spinal and epidural anesthesia or nerve block) will be used in group RA
Group GA
n=447 Participants
Method of anesthesia: general anesthesia method of anesthesia: Method of anesthesia includes: general anesthesia and regional anesthesia. General anesthesia(general anesthesia combined with peripheral nerve blockade, general anesthesia combined with spinal/epidural anesthesia or single general anesthesia) will be used in group GA. Regional anesthesia(epidural, spinal, combined spinal and epidural anesthesia or nerve block) will be used in group RA
30 Day Mortality
8 Participants
4 Participants

SECONDARY outcome

Timeframe: In 7days post operation

The worst pain score within 7 days post-operation in both groups. The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between no pain(0 point) to worst pain (100 points).

Outcome measures

Outcome measures
Measure
Group RA
n=471 Participants
Method of anesthesia: regional anesthesia method of anesthesia: Method of anesthesia includes: general anesthesia and regional anesthesia. General anesthesia(general anesthesia combined with peripheral nerve blockade, general anesthesia combined with spinal/epidural anesthesia or single general anesthesia) will be used in group GA. Regional anesthesia(epidural, spinal, combined spinal and epidural anesthesia or nerve block) will be used in group RA
Group GA
n=470 Participants
Method of anesthesia: general anesthesia method of anesthesia: Method of anesthesia includes: general anesthesia and regional anesthesia. General anesthesia(general anesthesia combined with peripheral nerve blockade, general anesthesia combined with spinal/epidural anesthesia or single general anesthesia) will be used in group GA. Regional anesthesia(epidural, spinal, combined spinal and epidural anesthesia or nerve block) will be used in group RA
Acute Pain Score Using Visual Analogue Scale (VAS)
0 score on a scale
Interval 0.0 to 20.0
0 score on a scale
Interval 0.0 to 10.0

SECONDARY outcome

Timeframe: till the day of discharge from hospital, an average of 7 days

Length of hospital stay are measured from the anesthesia starting day to the discharge day

Outcome measures

Outcome measures
Measure
Group RA
n=471 Participants
Method of anesthesia: regional anesthesia method of anesthesia: Method of anesthesia includes: general anesthesia and regional anesthesia. General anesthesia(general anesthesia combined with peripheral nerve blockade, general anesthesia combined with spinal/epidural anesthesia or single general anesthesia) will be used in group GA. Regional anesthesia(epidural, spinal, combined spinal and epidural anesthesia or nerve block) will be used in group RA
Group GA
n=471 Participants
Method of anesthesia: general anesthesia method of anesthesia: Method of anesthesia includes: general anesthesia and regional anesthesia. General anesthesia(general anesthesia combined with peripheral nerve blockade, general anesthesia combined with spinal/epidural anesthesia or single general anesthesia) will be used in group GA. Regional anesthesia(epidural, spinal, combined spinal and epidural anesthesia or nerve block) will be used in group RA
Length of Hospital Stay
7 days
Interval 5.0 to 10.0
7 days
Interval 6.0 to 10.0

SECONDARY outcome

Timeframe: 1 day after operation

Costs of anesthetic procedure only

Outcome measures

Outcome measures
Measure
Group RA
n=471 Participants
Method of anesthesia: regional anesthesia method of anesthesia: Method of anesthesia includes: general anesthesia and regional anesthesia. General anesthesia(general anesthesia combined with peripheral nerve blockade, general anesthesia combined with spinal/epidural anesthesia or single general anesthesia) will be used in group GA. Regional anesthesia(epidural, spinal, combined spinal and epidural anesthesia or nerve block) will be used in group RA
Group GA
n=471 Participants
Method of anesthesia: general anesthesia method of anesthesia: Method of anesthesia includes: general anesthesia and regional anesthesia. General anesthesia(general anesthesia combined with peripheral nerve blockade, general anesthesia combined with spinal/epidural anesthesia or single general anesthesia) will be used in group GA. Regional anesthesia(epidural, spinal, combined spinal and epidural anesthesia or nerve block) will be used in group RA
Costs of Anesthetic Procedure
159 dollars
Interval 110.0 to 220.0
268 dollars
Interval 201.0 to 359.0

SECONDARY outcome

Timeframe: till the day of discharge

Entire expenditure in-hospital

Outcome measures

Outcome measures
Measure
Group RA
n=471 Participants
Method of anesthesia: regional anesthesia method of anesthesia: Method of anesthesia includes: general anesthesia and regional anesthesia. General anesthesia(general anesthesia combined with peripheral nerve blockade, general anesthesia combined with spinal/epidural anesthesia or single general anesthesia) will be used in group GA. Regional anesthesia(epidural, spinal, combined spinal and epidural anesthesia or nerve block) will be used in group RA
Group GA
n=471 Participants
Method of anesthesia: general anesthesia method of anesthesia: Method of anesthesia includes: general anesthesia and regional anesthesia. General anesthesia(general anesthesia combined with peripheral nerve blockade, general anesthesia combined with spinal/epidural anesthesia or single general anesthesia) will be used in group GA. Regional anesthesia(epidural, spinal, combined spinal and epidural anesthesia or nerve block) will be used in group RA
Total In-hospital Costs
5582 dollars
Interval 4598.0 to 7362.0
5908 dollars
Interval 4778.0 to 7631.0

SECONDARY outcome

Timeframe: 6 months after discharge

in clinic or at their residence, diagnosed with Confusion Assessment Method (CAM)

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 12 months after discharge

in clinic or at their residence, diagnosed with Confusion Assessment Method (CAM)

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 6 months after discharge

using 36-Item Short Form Survey (SF-36) questionnaire

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 12months after discharge

using 36-Item Short Form Survey (SF-36) questionnaire

Outcome measures

Outcome data not reported

Adverse Events

Group RA

Serious events: 3 serious events
Other events: 83 other events
Deaths: 8 deaths

Group GA

Serious events: 2 serious events
Other events: 79 other events
Deaths: 4 deaths

Serious adverse events

Serious adverse events
Measure
Group RA
n=471 participants at risk
Method of anesthesia: regional anesthesia method of anesthesia: Method of anesthesia includes: general anesthesia and regional anesthesia. General anesthesia(general anesthesia combined with peripheral nerve blockade, general anesthesia combined with spinal/epidural anesthesia or single general anesthesia) will be used in group GA. Regional anesthesia(epidural, spinal, combined spinal and epidural anesthesia or nerve block) will be used in group RA
Group GA
n=471 participants at risk
Method of anesthesia: general anesthesia method of anesthesia: Method of anesthesia includes: general anesthesia and regional anesthesia. General anesthesia(general anesthesia combined with peripheral nerve blockade, general anesthesia combined with spinal/epidural anesthesia or single general anesthesia) will be used in group GA. Regional anesthesia(epidural, spinal, combined spinal and epidural anesthesia or nerve block) will be used in group RA
Cardiac disorders
acute myocardial infarction
0.21%
1/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
0.00%
0/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
Cardiac disorders
acute left heart failure
0.21%
1/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
0.00%
0/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
Gastrointestinal disorders
acute gastric perforation
0.21%
1/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
0.00%
0/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
Respiratory, thoracic and mediastinal disorders
lung infection
0.00%
0/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
0.21%
1/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
Nervous system disorders
stroke
0.00%
0/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
0.21%
1/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.

Other adverse events

Other adverse events
Measure
Group RA
n=471 participants at risk
Method of anesthesia: regional anesthesia method of anesthesia: Method of anesthesia includes: general anesthesia and regional anesthesia. General anesthesia(general anesthesia combined with peripheral nerve blockade, general anesthesia combined with spinal/epidural anesthesia or single general anesthesia) will be used in group GA. Regional anesthesia(epidural, spinal, combined spinal and epidural anesthesia or nerve block) will be used in group RA
Group GA
n=471 participants at risk
Method of anesthesia: general anesthesia method of anesthesia: Method of anesthesia includes: general anesthesia and regional anesthesia. General anesthesia(general anesthesia combined with peripheral nerve blockade, general anesthesia combined with spinal/epidural anesthesia or single general anesthesia) will be used in group GA. Regional anesthesia(epidural, spinal, combined spinal and epidural anesthesia or nerve block) will be used in group RA
Respiratory, thoracic and mediastinal disorders
Hypoxemia
2.3%
11/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
2.8%
13/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
Vascular disorders
Hypotension
2.8%
13/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
2.1%
10/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
Vascular disorders
Hypertension
0.85%
4/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
2.8%
13/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
Cardiac disorders
Arrhythmia
0.64%
3/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
0.85%
4/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
Cardiac disorders
Chest distress
0.64%
3/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
0.42%
2/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
Gastrointestinal disorders
Nausea and vomiting
10.0%
47/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
7.2%
34/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
Gastrointestinal disorders
Abdominal pain
0.42%
2/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
0.21%
1/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
Gastrointestinal disorders
Diarrhea
0.00%
0/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
0.21%
1/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
Gastrointestinal disorders
Acute gastric perforation*
0.21%
1/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
0.00%
0/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
Nervous system disorders
Headache and dizziness
0.42%
2/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
0.85%
4/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
Nervous system disorders
Stroke
0.00%
0/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
0.21%
1/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
General disorders
Numbness in the back
0.21%
1/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
0.00%
0/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
General disorders
Shiver
2.3%
11/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
2.3%
11/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
General disorders
Pharyngodynia
0.00%
0/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
0.21%
1/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
Skin and subcutaneous tissue disorders
Skin allergy
0.85%
4/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
0.21%
1/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
Skin and subcutaneous tissue disorders
Mild burns of skin
0.00%
0/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
0.21%
1/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
Nervous system disorders
Cerebrospinal fluid leak
0.00%
0/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
0.21%
1/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
General disorders
Hematoma in neck
0.21%
1/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
0.00%
0/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
General disorders
Hyperglycaemia
0.00%
0/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
0.21%
1/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
Renal and urinary disorders
Urinary retention
0.00%
0/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
0.21%
1/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
Blood and lymphatic system disorders
Anemia
0.00%
0/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.
0.21%
1/471 • Before discharge day with an average of 7 days, and for all cause mortality, is up to postoperative 30 days.

Additional Information

Ting Li

The second affiliated hospital and Yuying children's hospital of Wenzhou medical university

Phone: 008613587876896

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place